Active immunization against Alzheimer's β-amyloid peptide using phage display technology

Vaccine

Volumn 25, Issue 16 SPEC. ISS., 2007, Pages 3053-3056

  Solomon, Beka ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alzheimer's disease; Antibodies; Phage EFRH

Indexed keywords

AMYLOID BETA PROTEIN; ANTIGEN; EPITOPE; PEPTIDE;

ACTIVE IMMUNIZATION; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BACTERIOPHAGE; COGNITION; DATA ANALYSIS; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PATHOGENESIS; PHAGE DISPLAY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 33947596205     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.069     Document Type: Article

References (12)

1. Van Leuven F. Single and multiple transgenic mice as models for Alzheimer's disease. Prog Neurobiol 1 3 (2006) 305-312 [Review]
2. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373 (1995) 523-527
3. Schenk D., Barbour R., Dunn W., Gordan G., Grajeda H., Guido T., et al. Immunization with amyloid-β attenuates Alzheimer'disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
4. Weiner H.L., and Frenkel D. Immunology and immunotherapy of Alzheimer's disease. Nat Rev 6 (2006) 404-416
5. Sigurdsson E.M., Scholtzova H., Mehta P.D., Frangione B., and Wisniewski T. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol 159 (2001) 439-447
6. Frenkel D., Dewachter I., Van Leuven F., and Solomon B. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization. Vaccine 21 11/12 (2003) 1060-1065
7. Lavie V., Becker M., Cohen-Kupiec R., Yacoby I., Koppel R., Wedenig M., et al. EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris Water Maze trials. J Mol Neurosci 24 (2004) 105-113
8. Frenkel D., Balass M., and Solomon B. N-terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its anti-aggregating antibodies. J Neuroimmunol 8 (1998) 85-90
9. Frenkel D., Katz O., and Solomon B. Immunization against Alzheimer's beta-amyloid plaques via EFRH phage administration. Proc Natl Acad Sci USA 97 (2000) 11455-11459
10. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6 (2000) 916-919
11. Marvin D.A., Hale R.D., Nave C., and Citterich M.H. Molecular models and structural comparisons of native and mutant class I filamentous bacteriophages Ff (fd, fl, M13), If1 and Ike. J Mol Biol 235 (1994) 260-286
12. Galfre G., Monaci P., and Cortese R. Immunization with phage displayed mimotopes. Methods Enzymol 267 (1995) 109-115